In this episode of Medsider Radio, we sat down with Gabriel Sanchez, co-founder and CEO of Enspectra Health. The company's flagship VIO platform is the first FDA-cleared imaging modality for dermatology in over 25 years.

Gabriel holds a B.S. in mechanical engineering from MIT and an M.S. and Ph.D. from Stanford University, where he also served as an instructor in bioengineering and launched Enspectra to commercialize his groundbreaking research. VIO enables high-resolution, noninvasive imaging for skin cancer detection and health biometrics.

In this interview, Gabriel talks about his transition from academia to startups, how he narrowed down his idea to meet a pressing need in healthcare, the importance of speaking FDA’s language—or finding someone who does—and how he balances dilutive and non-dilutive funding.

Before we dive into the discussion, I wanted to mention a few things:

First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.

Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You’ll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!

We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ lifescience investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!

In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you’re interested, go to medsider.com/subscribe to learn more.

Lastly, if you'd rather read than listen, here's a link to the full interview with Gabriel Sanchez. 

In this episode of Medsider Radio, we sat down with Cary Vance, CEO of PhotoniCare. The company's FDA-cleared OtoSight™ Middle Ear Scope is a clinical diagnostic tool that offers a non-invasive and comprehensive assessment of middle ear fluid.

Cary is a proven medtech leader with over two decades of experience across large strategics like GE Healthcare and Covidien, and nearly 11 years as CEO of six different startups, including Titan Medical and Hansen Medical where he drove commercialization, fundraising, and M&A opportunities. He's been the Chairman, President, and CEO of PhotoniCare since May 2023.

In this interview, Cary shares why clinical evidence, workflow efficiency, and financial viability are the three pillars of medtech success and how he prepares for launches and M&As from day one.

Before we dive into the discussion, I wanted to mention a few things:

First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.

Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You’ll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!

We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ lifescience investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!

In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VI. If you’re interested, go to medsider.com/subscribe to learn more.

Lastly, if you'd rather read than listen, here's a link to the full interview with Cary Vance. 

In this episode of Medsider Radio, we sat down with Juan C. Jimenez, co-founder and CEO of AccurKardia, a startup developing software that uses ECG data to help doctors detect heart conditions more accurately and efficiently with AI.

Juan started his career as an investment banker specializing in M&A transactions, then moved on to become President of Puerto Rico’s largest non-emergency medical transportation company, TransCita. Now, he’s making waves in the ECG diagnostics space with AccurKardia. Leveraging his background in finance and healthcare, Juan brings unique expertise on efficiency and scale for medtech startups.

In this interview, Juan talks about how to scale sustainably with optimal dilution, giving your team space to establish a solid product, forging authentic relationships with potential customers, and leveraging your credibility to move your business forward.

Before we dive into the discussion, I wanted to mention a few things:

First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.

Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You’ll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!

We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ lifescience investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!

In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VI. If you’re interested, go to medsider.com/subscribe to learn more.

Lastly, if you'd rather read than listen, here's a link to the full interview with Juan C. Jimenez.

In this episode of Medsider Radio, we sat down with Dhruv Agrawal, CEO of Aether Biomedical. Aether's ZEUS bionic arm is a highly durable, multi-articulating prosthetic designed to handle everyday tasks with improved grip strength and resilience.

Dhruv found his true calling in building prosthetics while he was studying medicine and proceeded to co-found Aether when he was 18. Since starting Aether, he has helped raise over $15 million in funding and guided the launch of the ZEUS bionic hand, now deployed worldwide, including those impacted by the war in Ukraine.

In this interview, Dhruv discusses the importance of defining a clear problem statement, his approach to using grants to supplement VC funding, and the lessons he’s learned about evaluating market opportunities while operating globally.

Before we dive into the discussion, I wanted to mention a few things:

First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.

Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You’ll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!

We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ lifescience investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!

In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VI. If you’re interested, go to medsider.com/subscribe to learn more.

Lastly, if you'd rather read than listen, here's a link to the full interview with Dhruv Agrawal.

In this episode of Medsider Radio, we sat down with Steffen Hovard, CEO of Neuspera Medical, where his team is developing a novel, less invasive device that uses neuromodulation to treat conditions like overactive bladder.

Previously, Steffen spent two decades at Coloplast, where he held various senior leadership roles that contributed to the company’s growth, including the acquisition of a Minneapolis-based urology business in 2005. With deep expertise in the space, he has consistently driven growth and innovation across multiple functions, positioning himself as a leader of leaders in medtech, with board roles at Medical Alley and AdvaMed.

In this interview, Steffen talks about confirming market fit before investing, building an early network for key hires and investors, aligning development speed with each phase, engaging with regulators early, and taking a steady, relationship-driven approach to fundraising.

Before we dive into the discussion, I wanted to mention a few things:

First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.

Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You’ll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!

We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and a curated investor database to help you discover your next medical device or health technology investor!

In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VI. If you’re interested, go to medsider.com/subscribe to learn more.

Lastly, if you'd rather read than listen, here's a link to the full interview with Steffen Hovard.

In this episode of Medsider Radio, we sat down with returning guest, Don Crawford, CEO of CorVista Health. CorVista is developing a non-invasive medical device that uses advanced machine-learned algorithms to detect heart conditions, right in a doctor’s office.

Don's career began at Medtronic, followed by progressively senior sales and marketing roles at Guidant Corporation, Ventritex, and Intermedics, including overseeing a $100 million international cardiovascular business. Before CorVista, he led Sapheon, a venous device company, to a $238 million acquisition by Covidien.

In this interview, Don talks about the need for focus in startups, the importance of precise data collection, and the value of transparency and respect within teams. He also shares his approach to hiring and building a top-notch group of people.

Before we dive into the discussion, I wanted to mention a few things:

First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.

Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You’ll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!

We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and a curated investor database to help you discover your next medical device or health technology investor!

In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VI. If you’re interested, go to medsider.com/subscribe to learn more.

Lastly, if you'd rather read than listen, here's a link to the full interview with Don Crawford.

In this episode of Medsider Radio, we sat down with, Tim Rosa, CEO of Somnee, a company developing wearables based on personalized neuroscience to improve sleep quality. 

Previously, Tim was the CMO at Fitbit, where he played a key role in establishing the health and fitness wearables category. He built the organization’s global marketing function, contributing to the sale of over 140 million devices in 100+ countries. Additionally, he helped drive the company’s IPO and its eventual $2.1 billion sale to Google. Tim has also advised and worked with major brands like Electronic Arts, 2K Sports, ESPN Video Games, and Jasper Health.

In this interview, Tim shares insights on building and scaling successful brands based on real customer experiences, keeping messaging clear, and using brand strategy as a business foundation. He also shares why solid data and clinical evidence in OTC products are essential and how he generates value out of ongoing research.

Before we dive into the discussion, I wanted to mention a few things:

First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.

Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You’ll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!

We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and a curated investor database to help you discover your next medical device or health technology investor!

In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VI. If you’re interested, go to medsider.com/subscribe to learn more.

Lastly, if you'd rather read than listen, here's a link to the full interview with Tim Rosa.

In this episode of Medsider Radio, we sat down with medtech veteran, Eric Goslau, the co-founder and CEO of Transverse Medical. His startup is developing the Point Guard Cerebral Embolic Protection device that shields the brain from debris during cardiovascular procedures, reducing the risk of strokes.
 
Co-inventor of Point Guard, Eric has 29 years of experience in leadership roles across sales, marketing, and product development. At Transverse, Eric oversees all aspects of the company, including fundraising, clinical planning, and regulatory strategy. He has successfully raised over $14 million through innovative financing strategies.

In this interview, Eric shares how his background in sales helps him manage various functions of the company, how fundraising cycles have worked for Transverse, and his philosophy when it comes to product development: the enemy of good is perfect.

Before we dive into the discussion, I wanted to mention a few things:

First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.

Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You’ll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!

We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and a curated investor database to help you discover your next medical device or health technology investor!

In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VI. If you’re interested, go to medsider.com/subscribe to learn more.

Lastly, if you'd rather read than listen, here's a link to the full interview with Eric Goslau.

In this episode of Medsider Radio, we sat down with the exuberant Aakash Shah, co-founder and CEO of Wyndly, a telehealth startup that helps people overcome their allergies with personalized, at-home treatment plans.

Aakash was part of the Y Combinator W21 batch. As the CEO of Wyndly, he’s led the company from early inception through product development and eventual commercialization. Aakash holds dual degrees in Computer Science and Cognitive Science from the University of Virginia. Outside of Wyndly, he often presents on healthcare, telehealth, and startups, advises entrepreneurs, and hosts the Founders and Builders podcast.

In this interview, Aakash shares insights on simplifying healthcare access by meeting patients online and emphasizes the importance of learning by doing to accelerate personal and business growth. Aakash also talks about the power of storytelling when engaging customers and investors, and how to leverage video-based social media to reach both consumers and decision-makers effectively.

Before we dive into the discussion, I wanted to mention a few things:

First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.

Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You’ll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!

We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and a curated investor database to help you discover your next medical device or health technology investor!

In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VI. If you’re interested, go to medsider.com/subscribe to learn more.

Lastly, if you'd rather read than listen, here's a link to the full interview with Aakash Shah.

In this episode of Medsider Radio, we sat down with Ajay Shah, co-founder and CEO of Cytovale. The company is helping solve the sepsis problem with IntelliSep, a simple, cost-effective, and quick sepsis test. 

Ajay is a serial entrepreneur and engineer with expertise in cell-based diagnostic technologies. Before Cytovale, Ajay co-founded two other life sciences startups, one of which was acquired in 2012. In 2023, Ajay raised a Series C financing round of over $80 million and brought Cytovale’s sepsis test to market. 

In this interview, Ajay shares why CEOs should immerse themselves in the problem they’re hoping to tackle, how he nurtures relationships with investors over time, and his opinions on making the transition to entrepreneurship from a non-commercial career path. 

Before we dive into the discussion, I wanted to mention a few things:

First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.

Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You’ll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!

We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and a curated investor database to help you discover your next medical device or health technology investor!

In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VI. If you’re interested, go to medsider.com/subscribe to learn more.

Lastly, if you'd rather read than listen, here's a link to the full interview with Ajay Shah.